Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain
- PMID: 28595240
- DOI: 10.1097/j.pain.0000000000000947
Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain
Abstract
Toll-like receptor 7 (TLR7) is associated with the pathophysiology of systemic lupus erythematosus and Sjögren syndrome, well-known diseases accompanying interstitial cystitis (IC). We studied TLR7 expression in the bladder of patients with Hunner-type IC (HIC) and its functional roles in bladder inflammation and nociception using mice. Bladder biopsy specimens were obtained from patients with HIC. Specimens from the noncancerous portion of the bladder of patients with bladder cancer served as controls. The specimens were examined by immunohistochemistry and real-time polymerase chain reaction of TLR7. Loxoribine (LX), a TLR7 agonist, was instilled in the bladder of C57BL/6N female mice, and TLR7-mRNA expression and histological changes of the bladder, bladder pain-like licking behavior, voiding behavior, cystometry, and bladder afferent nerve activities were investigated. The effects of hydroxychloroquine, a TLR7 antagonist, on the LX-induced changes on cystometry and voiding behavior were studied. The number of TLR7 immuno-reactive cells and the mRNA expression of TLR7 were significantly increased in HIC specimens. Intravesical instillation of LX induced edema, congestion, inflammation, and significantly increased TLR7-mRNA expression in the mouse bladder. Loxoribine-instillation also significantly increased licking behavior, voiding frequency, and afferent nerve activities associated with decreased single-voided volume and intercontraction interval of micturitions. Hydroxychloroquine reversed the LX-induced cystometric and voiding behavioral changes. Toll-like receptor 7 was up-regulated in the bladder mucosa of patients with HIC, and activation of TLR7 in the mouse bladder induced cystitis with sensory hyperactivity of the bladder. Blocking the TLR7 pathway may be an innovative treatment target of HIC.
Similar articles
-
Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll-like receptor-7 agonist-induced experimental animal model in rat.BMC Urol. 2021 Nov 13;21(1):156. doi: 10.1186/s12894-021-00923-3. BMC Urol. 2021. PMID: 34774029 Free PMC article.
-
Long noncoding RNA (MEG3) in urinal exosomes functions as a biomarker for the diagnosis of Hunner-type interstitial cystitis (HIC).J Cell Biochem. 2020 Feb;121(2):1227-1237. doi: 10.1002/jcb.29356. Epub 2019 Oct 8. J Cell Biochem. 2020. PMID: 31595563
-
Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.Hum Gene Ther. 2017 Jul;28(7):598-609. doi: 10.1089/hum.2016.121. Epub 2017 Apr 18. Hum Gene Ther. 2017. PMID: 28446032 Free PMC article.
-
Phenotyping of interstitial cystitis/bladder pain syndrome.Int J Urol. 2019 Jun;26 Suppl 1:17-19. doi: 10.1111/iju.13969. Int J Urol. 2019. PMID: 31144756 Review.
-
Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships.Int J Urol. 2019 Jun;26 Suppl 1:20-24. doi: 10.1111/iju.13970. Int J Urol. 2019. PMID: 31144731 Review.
Cited by
-
Divergent histopathological and molecular patterns in chemically induced interstitial cystitis/bladder pain syndrome rat models.Sci Rep. 2024 Jul 12;14(1):16134. doi: 10.1038/s41598-024-67162-y. Sci Rep. 2024. PMID: 38997336 Free PMC article.
-
Analgesic Effect of the Kampo Formula Yokukansan via the Suppression of Substance P in an Experimental Rat Model of Hunner-Type Interstitial Cystitis.Cureus. 2024 Jan 14;16(1):e52238. doi: 10.7759/cureus.52238. eCollection 2024 Jan. Cureus. 2024. PMID: 38352105 Free PMC article.
-
Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis.iScience. 2023 Oct 21;26(11):108262. doi: 10.1016/j.isci.2023.108262. eCollection 2023 Nov 17. iScience. 2023. PMID: 38026177 Free PMC article.
-
Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months.Int Neurourol J. 2022 Sep;26(3):179-189. doi: 10.5213/inj.2244200.100. Epub 2022 Sep 30. Int Neurourol J. 2022. PMID: 36203251 Free PMC article.
-
The Japanese Herbal Medicine Yokukansan Exerted Antioxidant and Analgesic Effects in an Experimental Rat Model of Hunner-Type Interstitial Cystitis.Medicina (Kaunas). 2022 Jun 15;58(6):810. doi: 10.3390/medicina58060810. Medicina (Kaunas). 2022. PMID: 35744072 Free PMC article.
References
-
- Aizawa N, Homma Y, Igawa Y. Effects of mirabegron, a novel beta3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin. Eur Urol 2012;62:1165–73.
-
- Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
-
- Andersson KE, Soler R, Fullhase C. Rodent models for urodynamic investigation. Neurourol Urodyn 2011;30:636–46.
-
- Arends TJ, Lammers RJ, Falke J, van der Heijden AG, Rustighini I, Pozzi R, Ravic M, Eisenhardt A, Vergunst H, Witjes JA. Pharmacokinetic, pharmacodynamic, and activity evaluation of TMX-101 in a multicenter phase 1 study in patients with papillary non-muscle-invasive bladder cancer. Clin Genitourin Cancer 2015;13:204–9.e2.
-
- Collins VM, Daly DM, Liaskos M, McKay NG, Sellers D, Chapple C, Grundy D. OnabotulinumtoxinA significantly attenuates bladder afferent nerve firing and inhibits ATP release from the urothelium. BJU Int 2013;112:1018–26.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical